Sage Journals: Discover world-class research

Retricted access

Article commentary

First published 2021-6

Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectiveness

Jacopo Giuliani, Francesco Fiorica, Giovanni Ponturo [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

SIR-Spheres ® Y-90 resin microspheres in chemotherapy refractory or intolerant patients with metastatic colorectal cancer

Silvia Coretti, Filippo Rumi, Dario Sacchini [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Research article

First published 2026

Clinical outcomes of treatments for patients with refractory metastatic colorectal cancer: a systematic literature review and network meta-analysis

Julien Taieb, Sana Yahiaoui, Elias Choucair [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2021-8

Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial

Filippo Pietrantonio, Giovanni Fucà, Paolo Manca [...]

Tumori Journal

Open access

Research article

First published 2020-7

A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer

Guan-Li Su, Yuan-Yuan Wang, Jin-Cheng Wang [...]

Journal of International Medical Research

Open access

Research article

First published 2022

Efficacy and safety of raltitrexed plus S-1 versus regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study

Yu-Wen Zhou, Jia-Ling Wang, Qing-Fang Li [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2023-10

TK-1,TP,Ang-2,and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients

Beatrice Borelli, Stefania Crucitta, Alessandra Boccaccino [...]

Tumori Journal

Retricted access

News

First published 2016-11

Perspective: How to Improve Patient Selection in Refractory Metastatic Colorectal Cancer

Federica Marmorino, Chiara Cremolini, Filippo Pietrantonio

Tumori Journal

Retricted access

Research article

First published 2013-10

A Postmarketing Surveillance Study on Erbitux (Cetuximab) in Patients with Metastatic Colorectal Cancer Refractory to Irinotecan-Containing Treatment

Wen-Tsung Huang, Hong-Hwa Chen, Chung-Hung Yeh [...]

Journal of Investigative Medicine

Retricted access

Research article

First published 2022-7

Lonsurf (trifluridine/tipiracil): Assessing the impact of dose related toxicities and progression free survival in (refractory) metastatic colorectal cancer

Olivia R Court, Katherine Shemilt

Journal of Oncology Pharmacy Practice

Search results